EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis

Felipe González-Turén, Lorena Lobos-González, Alexander Riquelme-Herrera, Andrés Ibacache iD, Luis Meza Ulloa, Alexandra Droguett, Camila Alveal, Bastián Carrillo, Javiera Gutiérrez, Pamela Ehrenfeld iD, Areli Cárdenas-Oyarzo iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Felipe González-Turén und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Faculty of Health Sciences, Universidad Bernardo O'Higgins, Santiago 8370854, Chile. Hauptthemen laut MEDLINE: Receptor, Bradykinin B2, Cell Movement, Breast Neoplasms, Receptor, Bradykinin B1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FONDECYT, Agency of Research and Development of the Ministry of Science, Technology, Knowledge, and Innovation from the Chilean Government, Universidad Bernardo O’Higgins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kinin receptors B1 and B2 are involved in migration and invasion in gastric, glioma, and cervical cancer cells, among others. However, the role of kinin receptors in breast cancer cells has been poorly studied. We aimed to reveal the impact of B1 and B2 receptors on migration and invasion in breast cancer cells and demonstrate their capacity to modulate in vivo tumor growth. MDA-MB-231, MCF-7, and T47D cells treated with Lys-des[Arg9]bradykinin (LDBK) or bradykinin (BK) were used to evaluate migration and invasion. Des-[Arg9]-Leu8-BK and HOE-140 were used as antagonists for the B1 and B2 receptors. MDA-MB-231 cells incubated or not with antagonists were subcutaneously inoculated in BALBc NOD/SCID mice to evaluate tumor growth. LDBK and BK treatment significantly increased migration and invasion in breast cancer cells, effects that were negated when antagonists were used. The use of antagonists in vivo inhibited tumor growth. Moreover, the migration and invasion induced by kinins in breast cancer cells were inhibited when focal adhesion kinase (FAK) and Src inhibitors were used. The novelty revealed in our work is that B1 and B2 receptors activated by LDBK and BK induce migration and invasion in breast cancer cells via a mechanism that involves the FAK–Src signaling pathway, and the antagonism of both receptors in vivo impairs breast tumor growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Bradykinin B2Cell MovementBreast NeoplasmsReceptor, Bradykinin B1BradykininNeoplasm InvasivenessFocal Adhesion Kinase 1src-Family KinasesHumansAnimalsFemaleMiceCell Line, TumorSignal TransductionMice, SCIDMice, Inbred NODMice, Inbred BALB CMCF-7 CellsFocal Adhesion Protein-Tyrosine KinasesCell Proliferation

Stichwörter der Autor:innen

B1 receptorB2 receptorFAKSrcbreast cancerinvasionkinin receptorsmigration

Substanzen

Receptor, Bradykinin B2Receptor, Bradykinin B1BradykininFocal Adhesion Kinase 1src-Family KinasesPTK2 protein, humanFocal Adhesion Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • School of Nursing, Faculty of Health Sciences, Universidad Bernardo O'Higgins, Santiago 8370854, Chile.
  • Laboratory of Cellular Communication, Program of Cell and Molecular Biology, Biomedical Sciences Institute (ICBM), Faculty of Medicine, Universidad de Chile, Santiago 8370854, Chile.
  • Center for Regenerative Medicine, Institute for Sciences and Innovation in Medicine, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7610658, Chile.
  • Centro Integrativo de Biología y Química Aplicada (CIBQA), Faculty of Health Sciences, Universidad Bernardo O'Higgins, Santiago 8370854, Chile.
  • Laboratory of Molecular Design, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago 8370854, Chile.
  • School of Medical Technology, Faculty of Health Sciences, Universidad Bernardo O'Higgins, Santiago 8370854, Chile.

ORCID-Profile: Andrés Ibacache, Pamela Ehrenfeld, Areli Cárdenas-Oyarzo

Förderung

  • FONDECYT
  • Agency of Research and Development of the Ministry of Science, Technology, Knowledge, and Innovation from the Chilean Government
  • Universidad Bernardo O’Higgins

Zitieren

APA

González-Turén, F., Lobos-González, L., Riquelme-Herrera, A., Ibacache, A., Meza Ulloa, L., Droguett, A., Alveal, C., Carrillo, B., Gutiérrez, J., Ehrenfeld, P., & Cárdenas-Oyarzo, A. (2024). Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111709

Vancouver

González-Turén F, Lobos-González L, Riquelme-Herrera A, Ibacache A, Meza Ulloa L, Droguett A, et al. Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111709

BibTeX
@article{GonzlezTurn2024,
  author = {González-Turén, Felipe and Lobos-González, Lorena and Riquelme-Herrera, Alexander and Ibacache, Andrés and Meza Ulloa, Luis and Droguett, Alexandra and Alveal, Camila and Carrillo, Bastián and Gutiérrez, Javiera and Ehrenfeld, Pamela and Cárdenas-Oyarzo, Areli},
  title = {Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111709}
}
Kostenlos starten →